Chronic Disease Control

Association and clustering of overweight/obesity with cardiometabolic risks in adults in Guangxi: A cross-sectional study of 100,000 health examination participants

  • Chaochun WU ,
  • Yu PANG ,
  • Fatian LI ,
  • Jirong BAO
Expand
  • Health Management Center,the People's Hospital of Guangxi Zhuang Autonomous Region,Nanning 530021,Guangxi,China

Received date: 2026-02-26

  Online published: 2026-05-27

Abstract

Objective To investigate the prevalence of overweight/obesity and its association with cardiometabolic risk factors among adults in Guangxi and provide evidence for regional weight management and cardiometabolic disease prevention. Methods A cross-sectional study recruited 108,804 adults who underwent health examinations at the People's Hospital of Guangxi Zhuang Autonomous Region from January to December 2024. The participants were classified according to BMI into underweight, normal weight, overweight, and obese groups. Multivariate logistic regression, stratified and interaction analyses, risk factor clustering, and Cochran–Armitage trend tests were carried out. Results The prevalence rates of overweight, obesity, and central obesity were 35.95%, 13.30% (combined 49.25%), and 26.6%, respectively. Overweight/obesity was independently associated with hypertension, hyperglycemia, dyslipidemia, and fatty liver, and the strongest association was observed for fatty liver (obese group: OR = 25.03, 95%CI: 23.66–26.48, adjusted for age and sex). The combined analysis of BMI and central obesity indicated that individuals with both overweight/obesity and central obesity had the highest metabolic risks, with odds ratios (ORs) (95% confidence intervals [CI]) of 3.48 (3.33–3.63) for hypertension, 3.35 (3.17–3.55) for hyperglycemia, 2.76 (2.66–2.86) for dyslipidemia, and 14.18 (13.64–14.74) for fatty liver. Sex-stratified analyses disclosed stronger associations of overweight/obesity with hyperglycemia and fatty liver in women, and with dyslipidemia and hypertension in men (all interaction P < 0.05). Age-stratified analyses demonstrated the strongest associations in the 18–29 age group, and these associations declined with age (interaction P < 0.001). From underweight to obesity, the mean number of risk factors increased from 0.32 to 2.22, and the proportion of individuals with ≥3 risk factors rose from 0.45% to 36.92% (trend χ2 = 27753.48, P < 0.001). Conclusions The prevalence of overweight and obesity is notably high among adults in Guangxi. This high prevalence acts as a crucial driver of cardiometabolic risk factor clustering, and there are significant sex-and age-related differences in these associations. Additionally, the co-occurrence of overweight/obesity and central obesity synergistically exacerbates metabolic risks. Therefore, targeted weight management and comprehensive prevention strategies customized to regional characteristics are necessary.

Cite this article

Chaochun WU , Yu PANG , Fatian LI , Jirong BAO . Association and clustering of overweight/obesity with cardiometabolic risks in adults in Guangxi: A cross-sectional study of 100,000 health examination participants[J]. The Journal of Practical Medicine, 2026 , 42(10) : 1729 -1736 . DOI: 10.3969/j.issn.1006-5725.2026.10.006

References

[1] NG M, GAKIDOU E, LO J, et al. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: A forecasting study for the Global Burden of Disease Study 2021[J]. Lancet, 2025, 405(10481): 813-838. doi:10.1016/S0140-6736(25)00355-1 .
[2] 国家卫生健康委. 中国居民营养与慢性病状况报告-2020年[M]. 北京: 人民卫生出版社, 2021.
[3] DROZDZ D, ALVAREZ-PITTI J, WóJCIK M, et al. Obesity and cardiometabolic risk factors: From childhood to adulthood[J]. Nutrients, 2021, 13(11): 4176. doi:10.3390/nu13114176 .
[4] KIVIM?KI M, KUOSMA E, FERRIE J E, et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: Pooled analysis of individual-level data for 120?813 adults from 16 cohort studies from the USA and Europe[J]. Lancet Public Health, 2017, 2(6): e277-e285. doi:10.1016/S2468-2667(17)30074-9 .
[5] 陈佩琴, 周泽文, 莫秋燕, 等. 广西壮族人群腹型肥胖流行情况及其影响因素分析[J]. 广西医科大学学报, 2021, 38(2): 388-392. doi:10.16190/j.cnki.45-1211/r.2021.02.029 .
[6] 国家卫生健康委员会肥胖症诊疗指南编写委员会, 张忠涛, 纪立农. 肥胖症诊疗指南(2024年版)[J]. 中国循环杂志, 2025, 40(1): 6-30. doi:10.3969/j.issn.1000-3614.2025.01.002 .
[7] 中国高血压防治指南修订委员会, 高血压联盟(中国, 中华医学会心血管病学分会中国医师协会高血压专业委员会, 等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019,24(1): 24-56. doi:10.3969/j.issn.1007-5410.2019.01.002 .
[8] 中华医学会糖尿病学分会,国家基本公共卫生服务项目基层糖尿病防治管理办公室.国家基层糖尿病防治管理指南(2025版)[J].中华内科杂志, 2025, 64(12): 1169-1186. doi:10.3760/cma.j.cn112338-20250815-00567 .
[9] 中国血脂管理指南修订联合专家委员会. 中国血脂管理指南(2023年)[J]. 中国循环杂志, 2023, 38(3): 237-271. doi:10.3969/j.issn.1000-3614.2023.03.001 .
[10] 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018更新版)[J]. 现代医药卫生, 2018, 34(5): 641-649. doi:10.3969/j.issn.1009-5519.2018.05.001 .
[11] GUO X, GONG S, CHEN Y, et al. Lifestyle behaviors and stress are risk factors for overweight and obesity in healthcare workers: A cross-sectional survey[J]. BMC Public Health, 2023, 23(1): 1791. doi:10.1186/s12889-023-16673-w .
[12] ZHAO Z, LU H, MENG R, et al. Risk factor analysis and risk prediction study of obesity in steelworkers: Model development based on an occupational health examination cohort dataset[J]. Lipds Health Dis, 2024, 23(1): 10. doi:10.1186/s12944-023-01994-x .
[13] CHEN K, SHEN Z, GU W, et al. Prevalence of obesity and associated complications in China: A cross-sectional, real-world study in 15.8 million adults[J]. Diabetes Obesity Metabolism, 2023, 25(11): 3390-3399. doi:10.1111/dom.15238 .
[14] QUEK J, CHAN K E, WONG Z Y, et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: A systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2023, 8(1): 20-30. doi:10.1016/S2468-1253(22)00317-X .
[15] LEE M J, KIM J. The pathophysiology of visceral adipose tissues in cardiometabolic diseases[J]. Biochem Pharmacol, 2024, 222: 116116. doi:10.1016/j.bcp.2024.116116 .
[16] SHI Z, WONG J, BROOKS V L. Obesity: Sex and sympathetics[J]. Biol Sex Differ, 2020, 11(1): 10. doi:10.1186/s13293-020-00286-8 .
[17] ROSS R, NEELAND I J, YAMASHITA S, et al. Waist circumference as a vital sign in clinical practice: A Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity[J]. Nat Rev Endocrinol, 2020, 16(3): 177-189. doi:10.1038/s41574-019-0310-7 .
[18] LU X, WANG Q, LIANG H, et al. Contribution of different phenotypes of obesity to metabolic abnormalities from a cross-sectional study in the northwest China[J]. Diabetes Metab Syndr Obes Targets Ther, 2021, 14: 3111-3121. doi:10.2147/dmso.s314935 .
[19] DE PAOLI M, ZAKHARIA A, WERSTUCK G H. The role of estrogen in insulin resistance a review of clinical and preclinical data[J]. Am J Pathol, 2021, 191(9): 1490-1498. doi:10.1016/j.ajpath.2021.05.011 .
[20] CHANG M, SHAO Z, WEI W, et al. Sex-specific prevalence and risk factors of metabolic-associated fatty liver disease among 75,570 individuals in eastern China[J]. Front Endocrinol (Lausanne), 2023, 14: 1241169. doi:10.3389/fendo.2023.1241169 .
[21] CHEN Y, YU W, LV J, et al. Early adulthood BMI and cardiovascular disease: A prospective cohort study from the China Kadoorie Biobank[J]. Lancet Public Health, 2024, 9(12): e1005-e1013. doi:10.1016/S2468-2667(24)00043-4 .
[22] SUN J, ZHOU W, GU T, et al. A retrospective study on association between obesity and cardiovascular risk diseases with aging in Chinese adults[J]. Sci Rep, 2018, 8(1): 5806. doi:10.1038/s41598-018-24161-0 .
[23] AO L, WILLEMS VAN DIJK K, VAN HEEMST D, et al. Differential and sex- and age-specific risks of cardiometabolic diseases with unrelated metabolic syndrome dimensions[J]. Obesity, 2023, 31(7): 1933-1941. doi:10.1002/oby.23778 .
[24] CAMELL C D. Adipose tissue microenvironments during aging: Effects on stimulated lipolysis[J]. Biochim Biophys Acta Mol Cell Biol Lipids, 2022, 1867(5): 159118. doi:10.1016/j.bbalip.2022.159118 .
[25] MISRA A, JOSHI S, MITHAL A. Malnutrition-related diabetes mellitus: Rushing toward “type 5” amid unresolved questions and limited evidence[J]. Diabetes Metab Syndr Clin Res Rev, 2025, 19(5): 103250. doi:10.1016/j.dsx.2025.103250 .
[26] 孔维敏,杨圣楠,楼青青,等.心周脂肪与心血管危险因素相关性研究进展[J].中国热带医学,2016,16(2):190-194.doi:10.13604/j.cnki.46-1064/r.2016.02.27 .
[27] TUNE J D, GOODWILL A G, SASSOON D J, et al. Cardiovascular consequences of metabolic syndrome[J]. Transl Res, 2017, 183: 57-70. doi:10.1016/j.trsl.2017.01.001 .
[28] 伍朝春, 黄政德, 庞羽, 等. 肥胖症多学科协作诊疗模式研究进展[J]. 实用医学杂志, 2023, 39(12): 1588-1592. doi:10.3969/j.issn.1006-5725.2023.12.022 .
Outlines

/